☆ 4.5 Article

The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: Evolution and current status (2005-2011)

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2011)

期刊

JOURNAL OF HEART AND LUNG TRANSPLANTATION

卷 30, 期 6, 页码 601-611

出版社

ELSEVIER SCIENCE INC

DOI: 10.1016/j.healun.2011.02.015

关键词

-

类别

Cardiac & Cardiovascular Systems Respiratory System Surgery Transplantation

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Urology & Nephrology

The Clinical and Pathologic Phenotype of Antibody-Mediated Vascular Rejection Diagnosed Using Arterial C4d Immunoperoxidase

Brian J. Nankivell, Meena Shingde, Chow H. P'Ng, Ankit Sharma

Summary: This study suggests that arterial C4d (C4d(art)) immunoperoxidase deposition may serve as a suggestive biomarker for antibody-mediated vascular rejection. Inclusion of C4d(art) in the diagnostic schema improves the sensitivity and accuracy of diagnosis for antibody-mediated vascular rejection and aids in the etiologic classification of arteritis.

KIDNEY INTERNATIONAL REPORTS (2022)

添加到收藏夹

Article Health Care Sciences & Services

Acute Antibody-Mediated Rejection in Liver Transplant Recipients with Autoimmune Liver Disease: A Clinical and Pathologic Study of 4 Cases

Hongmei Jiang, Hui Guo, Bo Yang, Yuanyuan Zhao, Lai Wei, Zhishui Chen, Dong Chen

Summary: This case series explores the characteristics and outcomes of acute AMR in liver transplant recipients with autoimmune liver disease (ALD). The incidence of acute AMR in ALD patients was higher compared to non-ALD recipients. Individualized therapies based on clinical manifestations resulted in good prognoses for most patients.

JOURNAL OF PERSONALIZED MEDICINE (2023)

添加到收藏夹

Article Immunology

Artemisinin Attenuates Transplant Rejection by Inhibiting Multiple Lymphocytes and Prolongs Cardiac Allograft Survival

Zhe Yang, Fei Han, Tao Liao, Haofeng Zheng, Zihuan Luo, Maolin Ma, Jiannan He, Lei Li, Yongrong Ye, Rui Zhang, Zhengyu Huang, Yannan Zhang, Qiquan Sun

Summary: Artemisinin demonstrates significant immunosuppressive effects in rat cardiac transplantation model, attenuating rejection reactions and prolonging allograft survival. By targeting multiple effector cells, artemisinin effectively reduces T cell-mediated rejection and antibody-mediated rejection, showing potential for clinical use in transplant rejection prevention.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

A modified perioperative regimen for deceased donor kidney transplantation in presensitized recipients without prior desensitization therapy

Zhiliang Guo, Daqiang Zhao, Rula Sa, Lu Wang, Songxia Li, Guangyuan Zhao, Lan Zhu, Gang Chen

Summary: A modified IVIG-based perioperative regimen can achieve excellent intermediate-term graft and recipient survival outcomes in presensitized patients who received deceased donor kidney transplantation without prior desensitization.

FRONTIERS IN IMMUNOLOGY (2023)

添加到收藏夹

Review Immunology

Current Status of ABO-incompatible Liver Transplantation

Hiroto Egawa, Hideki Ohdan, Kazuhide Saito

Summary: By 2014, strategies to prevent antibody-mediated rejection (AMR) after ABO-incompatible (ABO-I) living donor liver transplantation (LDLT) were established in Japan and expanded primarily to Asia. The best option currently is a desensitization protocol including rituximab, plasma pheresis, tacrolimus, and mycophenolate mofetil. Strategies are needed to distinguish patients at high risk of AMR from those at low risk and to adjust immunosuppression to prevent both AMR and infection.

TRANSPLANTATION (2023)

添加到收藏夹

Review Medicine, General & Internal

The New Challenge in Pediatric Liver Transplantation: Chronic Antibody-Mediated Rejection

Elena Yukie Uebayashi, Hideaki Okajima, Miki Yamamoto, Eri Ogawa, Tatsuya Okamoto, Hironori Haga, Etsurou Hatano

Summary: Antibody-mediated rejection (AMR) of liver allograft transplantation has gained clinical awareness as a potential cause of chronic liver injury and graft failure. The accurate incidence, diagnostic criteria, and treatment protocols of chronic AMR in pediatric patients remain unclear and further research is needed.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Antibody-mediated rejection of the liver allograft: An update and a clinico-pathological perspective

Brian T. Lee, M. Isabel Fiel, Thomas D. Schiano

Summary: Antibody-mediated rejection after liver transplantation is a lesser recognized cause of allograft injury, with challenges in timely diagnosis and treatment, highlighting the need for further research and development in this area.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Intimal Arteritis and Microvascular Inflammation Are Associated With Inferior Kidney Graft Outcome, Regardless of Donor-Specific Antibodies

Marek Novotny, Petra Hruba, Martin Kment, Ludek Voska, Katerina Kabrtova, Antonij Slavcev, Ondrej Viklicky

Summary: This study found that intimal arteritis as part of ABMR represented a risk for early development of transplant glomerulopathy regardless of DSA status. In DSA positive ABMR, intimal arteritis was associated with a high-risk phenotype.

FRONTIERS IN MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Phenotyping CLAD after single lung transplant: Limits and prognostic assessment of the 2019 ISHLT classification system

Gregory Berra, Ella Huszti, Liran Levy, Mitsuaki Kawashima, Eyal Fuchs, Benjamin Renaud-Picard, Peter Riddell, Olivia Dias, Srinivas Rajagopala, Ambilly Ulahannan, Rasheed Ghany, Lianne Gail Singer, Jussi Tikkanen, Tereza Martinu

Summary: Phenotyping chronic lung allograft dysfunction (CLAD) in single lung transplant (SLTX) is challenging. This study assessed the applicability and prognostic performance of International Society for Heart and Lung Transplantation (ISHLT) classification in SLTX. The results showed that a classification relying on imaging obtained better prognostic performance than a classification using physiological cut-offs.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Therapies for Chronic Allograft Rejection

Min Young Kim, Daniel C. Brennan

Summary: Significant progress has been made in the pathophysiology, diagnosis, and treatment of antibody-mediated rejection (ABMR) in recent decades, but effective treatment for chronic ABMR remains a challenge. Chronic ABMR has a distinct phenotype from active ABMR and is mainly caused by de novo donor specific antibodies (DSA), leading to progressive graft injury.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Antibody-mediated allograft rejection is associated with an increase in peripheral differentiated CD28-CD8

Hoa Le Mai, Nicolas Degauque, Sabine Le Bot, Marie Rimbert, Karine Renaudin, Richard Danger, Florent Le Borgne, Clarisse Kerleau, Gaelle Tilly, Anais Vivet, Florent Delbos, Alexandre Walencik, Magali Giral, Sophie Brouard

Summary: The study found that the percentage and absolute number of CD28-CD8+ T cells were significantly increased in kidney transplant patients with antibody-mediated rejection (ABMR). Moreover, CD28-CD8+ T cells from patients with ABMR showed a more rigorous response to stimulation compared to their CD28+ counterparts. These findings suggest that differentiated CD28-CD8+ T cells, with increased frequency, number, and function, may play a role in the pathobiology of ABMR.

EBIOMEDICINE (2022)

添加到收藏夹

Article Surgery

A noninvasive diagnostic approach to retrospective donor HLA typing in kidney transplant patients using urine

Christian Bach, Karl X. Knaup, Markus Herrmann, Mandy Krumbiegel, Frederick Pfister, Maike Buettner-Herold, Martin Steffen, Daniel Zecher, Kai Lopau, Karen Schneider, Anne Dieterle, Kerstin Amann, Andre Reis, Mario Schiffer, Bernd M. Spriewald, Michael S. Wiesener

Summary: Antibody-mediated rejection (AMR) poses a significant challenge to long-term kidney transplantation, primarily caused by donor-specific HLA antibodies. The lack of available donor DNA often hinders the assessment of HLA antibody specificity. The study demonstrates the feasibility and diagnostic value of establishing donor renal tubular cell cultures from recipient's urine to solve this issue and accurately determine donor-specificity of HLA antibodies in kidney transplant patients.

TRANSPLANT INTERNATIONAL (2021)

添加到收藏夹

Article Cell Biology

Donor plasma mitochondrial DNA is associated with antibody-mediated rejection in renal allograft recipients

Fei Han, Qipeng Sun, Zhengyu Huang, Heng Li, Maolin Ma, Tao Liao, Zihuang Luo, Lingling Zheng, Nana Zhang, Nan Chen, Liangqing Hong, Ning Na, Qiquan Sun

Summary: The study reveals that donor plasma mitochondrial DNA (dmtDNA) levels are correlated with the occurrence of antibody-mediated rejection (ABMR) in renal allograft recipients. Higher dmtDNA levels are associated with acute rejection and ABMR, presenting dmtDNA as a potential predictive marker for ABMR in organ evaluation.

AGING-US (2021)

添加到收藏夹

Article Immunology

Perturbations of the T-cell immune repertoire in kidney transplant rejection

Tara K. Sigdel, Paul A. Fields, Juliane Liberto, Izabella Damm, Maggie Kerwin, Jill Hood, Parhom Towfighi, Marina Sirota, Harlan S. Robins, Minnie M. Sarwal

Summary: In this study, researchers analyzed the T-cell repertoire in kidney transplant recipients and found that changes in the repertoire are associated with post-transplant rejection episodes. T-cell receptor sequencing may serve as a valuable tool for predicting rejection risk after transplantation.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Clinical and Pathologic Feature of Patients With Early Versus Late Active Antibody-Mediated Rejection After Kidney Transplantation: A Single-Center Experience

Zixuan Wu, Longhui Qiu, Chang Wang, Xiaomian Liu, Qihao Li, Shuangjin Yu, Yuan Yue, Jie Li, Wutao Chen, Jiajian Lai, Lizhong Chen, Changxi Wang, Guodong Chen

Summary: This study compared clinical features between early and late active antibody-mediated rejection (aABMR). Late aABMR group had more severe pathological features, and multivariate Cox regression analysis identified high levels of serum creatinine or proteinuria along with concomitant T-cell-mediated rejection as independent risk factors for allograft failure in aABMR patients.

TRANSPLANTATION PROCEEDINGS (2021)

添加到收藏夹

Article Surgery

Clinical recommendations for posttransplant assessment of anti-HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document

Carmen Lefaucheur, Kevin Louis, Anna B. Morris, Jean-Luc Taupin, Peter Nickerson, Anat R. Tambur, Howard M. Gebel, Elaine F. Reed

Summary: This consensus report provides clinical practice recommendations in kidney, heart, lung, and liver transplantation based on expert assessment of quality and strength of evidence regarding the relationship between anti-HLA donor-specific antibodies and transplant outcome. The recommendations address major clinical problems in transplantation, including the clinical implications of positive posttransplant DSA detection, the relevance of posttransplant DSA assessment for diagnosis and treatment management, and the relevance of posttransplant DSA for allograft prognosis and risk stratification.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Assessment and management of allosensitization following heart transplant in adults

Abhishek Jaiswal, Jennifer Bell, Ersilia M. DeFilippis, Evan P. Kransdorf, Jignesh Patel, Jon A. Kobashigawa, Michelle M. Kittleson, David A. Baran

Summary: Immunological injury, particularly caused by antibodies to de novo donor specific human leukocyte antigen (dnDSA) and antibody mediated injury and rejection, is a major challenge in heart transplantation. Current immunoassays are limited in unraveling the pathogenic potential of dnDSA, and the role of dnDSA is continuously evaluated. The timing and frequency of dnDSA monitoring, early detection, and risk mitigation, as well as management, remain challenging. A strategic approach that combines diagnostic assays, clinical presentation, and allograft injury/rejection is needed for tailored therapeutics. This review aims to outline the contemporary knowledge on detection, monitoring, and management of dnDSA after heart transplantation and propose a diagnostic and therapeutic approach to minimize morbidity and mortality while balancing adverse reactions from pharmacotherapy.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Detection and management of HLA sensitization in candidates for adult heart transplantation

Ersilia M. DeFilippis, Evan P. Kransdorf, Abhishek Jaiswal, Xiaohai Zhang, Jignesh Patel, Jon A. Kobashigawa, David A. Baran, Michelle M. Kittleson

Summary: Heart transplantation is the preferred therapy for advanced heart failure patients, but finding a suitable donor for sensitized candidates with human leukocyte antigen antibodies can be challenging. The increasing number of sensitized patients awaiting transplantation is likely due to the use of durable and mechanical circulatory support and the presence of congenital heart disease. This review discusses the assessment of human leukocyte antigen antibodies, desensitization strategies, donor selection methods, and induction management.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Donor hyperoxia is a novel risk factor for severe cardiac primary graft dysfunction

Evan P. Kransdorf, Joshua A. Rushakoff, Jiho Han, Lillian Benck, Darren Malinoski, Dominic Emerson, Pedro Catarino, Reinaldo Rampolla, Jon A. Kobashigawa, Kiran K. Khush, Jignesh K. Patel

Summary: This study evaluated the risk factors for primary graft dysfunction (PGD) after heart transplant surgery. The excessive oxygen supplementation during donor management was found to be associated with an increased risk of severe PGD and early recipient death. Therefore, minimizing excessive oxygen supplementation is recommended in donor management.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

添加到收藏夹

Article Clinical Neurology

Multimodal evaluation of carpal tunnel syndrome in a pre-symptomatic TTR mutation carrier

A. Salvalaggio, M. Cacciavillani, C. Tiengo, A. Cipriani, L. Frizziero, M. Fedrigo, S. Rizzo, A. Angelini, R. Gasparotti, C. Briani

JOURNAL OF THE NEUROLOGICAL SCIENCES (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Is Congenital Muscular Mitral-Aortic Discontinuity Another Feature of Obstructive Hypertrophic Cardiomyopathy? A Pathology Validation Study

Monica De Gaspari, Mariachiara Mazzucato, Maria Bueno Marinas, Annalisa Angelini, Chiara Calore, Martina Perazzolo Marra, Kalliopi Pilichou, Domenico Corrado, Gaetano Thiene, Stefania Rizzo, Cristina Basso

Summary: The study validates the existence of a muscular mitral-aortic discontinuity during surgery in patients with hypertrophic cardiomyopathy. It reveals that the left atrial myocardium extends into the inter-valvular fibrosa, and its length decreases with age.

LABORATORY INVESTIGATION (2023)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Donor Diabetes Mellitus Status and Contemporary Outcomes After Cardiac Transplantation

John W. Ostrominski, Sara R. Machado, Elias Mossialos, Mandeep R. Mehra, Muthiah Vaduganathan

JACC-HEART FAILURE (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Hemodynamic-Guided Heart Failure Management in Patients With Either Prior HF Hospitalization or Elevated Natriuretic Peptides

Akshay S. Desai, Alan Maisel, Mandeep R. Mehra, Michael R. Zile, Anique Ducharme, Sara Paul, Samuel F. Sears, Frank Smart, Kunjan Bhatt, Selim Krim, John Henderson, Nessa Johnson, Philip B. Adamson, Maria Rosa Costanzo, Joann Lindenfeld

Summary: This study assessed the efficacy and safety of hemodynamic-guided heart failure (HF) management in patients with elevated natriuretic peptides (NPs) but no recent HF hospitalization (HFH). The results showed consistent effects of hemodynamic monitoring in both patient groups, supporting the consideration of hemodynamic monitoring in the expanded group of chronic HF patients with elevated NPs.

JACC-HEART FAILURE (2023)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Life-Prolonging Benefits of LVAD Therapy in Advanced Heart Failure A Clinician's Action and Communication Aid

Mandeep R. Mehra, Aditi Nayak, Akshay S. Desai

Summary: Contemporary durable LVAD therapy remains an important approach in the care paradigm for patients with advanced HF. We suggest a strategy to timely recognize disease progression, effectively communicate therapeutic benefits, and enhance life quality and expectancy through timely referral and treatment for these vulnerable patients.

JACC-HEART FAILURE (2023)

添加到收藏夹

Article Cell Biology

Deficiency of the CD155-CD96 immune checkpoint controls IL-9 production in giant cell arteritis

Shozo Ohtsuki, Chenyao Wang, Ryu Watanabe, Hui Zhang, Mitsuhiro Akiyama, Melanie C. Bois, Joseph J. Maleszewski, Kenneth J. Warrington, Gerald J. Berry, Jorg J. Goronzy, Cornelia M. Weyand

Summary: Loss of function of inhibitory immune checkpoints can lead to autoimmune disease, such as giant cell arteritis (GCA). In this study, a defective CD155-CD96 immune checkpoint was found in GCA patients, resulting in the retention of CD155 in the endoplasmic reticulum (ER) of macrophages. Antigen-presenting cells with low CD155 expression induced the expansion of tissue invasive CD4+CD96+ T cells that released interleukin-9 (IL-9). The dysregulated immune response caused vessel wall destruction, which could be suppressed by anti-IL-9 antibodies in a GCA mouse model.

CELL REPORTS MEDICINE (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation

Leonardo Schirone, Daniele Vecchio, Valentina Valenti, Maurizio Forte, Michela Relucenti, Annalisa Angelini, Tania Zaglia, Sonia Schiavon, Luca DAmbrosio, Gianmarco Sarto, Rosita Stanzione, Elisa Mangione, Selenia Miglietta, Anna Di Bona, Marny Fedrigo, Alessandra Ghigo, Francesco Versaci, Vincenzo Petrozza, Simona Marchitti, Speranza Rubattu, Massimo Volpe, Junichi Sadoshima, Luigi Frati, Giacomo Frati, Sebastiano Sciarretta

Summary: Heart failure is a common side effect of doxorubicin (DOX) treatment in cancer patients. This study aimed to investigate the role of the serine/threonine kinase MST1 in the development of DOX-induced heart failure. The results showed that MST1 signaling was activated in response to DOX treatment in mice and human myocardial tissue. Inhibition of MST1 attenuated DOX-induced cardiac dysfunction through the upregulation of SIRT3, a mitochondrial protection enzyme. These findings suggest that MST1 contributes to DOX-induced cardiomyopathy by downregulating SIRT3.

CELLULAR AND MOLECULAR LIFE SCIENCES (2023)

添加到收藏夹

Article Clinical Neurology

Impact of Carotid Stent Design on Embolic Filter Debris Load During Carotid Artery Stenting

Francesco Squizzato, Michele Piazza, Edoardo Forcella, Elda Chiara Colacchio, Marny Fedrigo, Annalisa Angelini, Franco Grego, Michele Antonello

Summary: This study compared the quantity of embolized material captured by filters during carotid artery stenting using different stent designs. The use of micromesh stents was associated with a lower embolization rate and embolic filter debris load, especially in patients with hypoechogenic and long plaques and preoperative evidence of asymptomatic ischemic cerebral lesion.

STROKE (2023)

添加到收藏夹

Article Urology & Nephrology

Human parietal epithelial cells (PECs) and proteinuria in lupus nephritis: a role for ClC-5, megalin, and cubilin?

Monica Ceol, Lisa Gianesello, Hernan Trimarchi, Alberto Migliorini, Giovanna Priante, Claudia M. Radu, Elena Naso, Annalisa Angelini, Lorenzo A. Calo, Franca Anglani, Dorella Del Prete

Summary: This study investigated the role of ClC-5, megalin, and cubilin in parietal epithelial cells and found that the number of hypertrophic parietal epithelial cells was significantly higher in lupus nephritis patients. The presence of these cells in Bowman's capsule may provide a potential resource for responding to protein overload in other glomerulonephritis.

JOURNAL OF NEPHROLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Diffuse Panbronchiolitis in a Patient With Ulcerative Colitis Treated With Ustekinumab

Meghan Marmor, Gerald Berry, Rishi Raj

ACG CASE REPORTS JOURNAL (2023)

添加到收藏夹

Review Oncology

Severe Fatal Mucormycosis in a Patient with Chronic Lymphocytic Leukaemia Treated with Zanubrutinib: A Case Report and Review of the Literature

Giuseppe Maggioni, Marny Fedrigo, Andrea Visentin, Elisa Carturan, Valeria Ruocco, Livio Trentin, Mauro Alaibac, Annalisa Angelini

Summary: We present a fatal case of severe mucormycosis in a 74-year-old Caucasian woman with CLL treated with zanubrutinib. Despite therapeutic efforts, the patient died.

CURRENT ONCOLOGY (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.